,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,KEGG_2021_Human,Phototransduction,8/28,0.0207338129255901,0.999995789583929,0,0,2.732862745098039,10.592547131987342,GRK1;GUCY2D;GNAT2;PDE6G;GNB1;RHO;PDE6B;GNAT1
1,KEGG_2021_Human,Thiamine metabolism,5/15,0.0338968733800364,0.999995789583929,0,0,3.4140227183705445,11.554529442175532,ALPP;AK1;ALPI;ALPG;AK8
2,KEGG_2021_Human,Platelet activation,22/124,0.0686631024855887,0.999995789583929,0,0,1.474763406940063,3.9502176512354055,FGB;PTGIR;PPP1R12A;PLA2G4D;ROCK2;NOS3;PLA2G4C;RASGRP2;MYLK3;ACTG1;MYL12B;PIK3R5;ADCY5;PPP1CA;GP9;PLCB3;AKT2;P2RX1;P2RY1;TLN2;PLCB2;FERMT3
3,KEGG_2021_Human,Protein digestion and absorption,18/103,0.1035326460191512,0.999995789583929,0,0,1.4470866141732284,3.281801853178583,COL28A1;COL18A1;CPA1;SLC6A19;COL13A1;CTRB2;ELN;ATP1B2;PGA3;SLC8A2;PGA4;SLC9A3;SLC7A9;FXYD2;COL6A2;COL8A2;COL6A3;COL9A2
4,KEGG_2021_Human,cGMP-PKG signaling pathway,27/167,0.1177335019245795,0.999995789583929,0,0,1.3183778292035897,2.8204474390147505,ROCK2;MYLK3;SLC8A2;PIK3R5;ADCY5;NPPC;PPP3R1;CREB3L3;AKT2;ADORA1;MEF2A;MEF2C;PPP1R12A;NOS3;IRAG1;ATP2B3;ATP1B2;ADRA2B;PPP1CA;PLCB3;FXYD2;KCNMA1;PPIF;GTF2IRD1;PDE5A;MYL9;PLCB2
5,KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,10/53,0.1327300273507756,0.999995789583929,0,0,1.5880216129385565,3.206911322241114,PLCB3;KLK1;FXYD2;ATP2B3;PTH1R;ATP1B2;AP2A2;PLCB2;ESR1;SLC8A2
6,KEGG_2021_Human,Proximal tubule bicarbonate reclamation,5/23,0.1623462714147112,0.999995789583929,0,0,1.8958088523305916,3.44662551337988,SLC9A3;FXYD2;SLC25A10;ATP1B2;SLC38A3
7,KEGG_2021_Human,Oxytocin signaling pathway,24/154,0.1770697490754637,0.999995789583929,0,0,1.2612713253597232,2.183527500597364,RYR1;KCNJ4;MEF2C;PPP1R12A;PLA2G4D;ROCK2;KCNJ12;NOS3;PLA2G4C;CAMK2A;CACNA2D2;MYLK3;ACTG1;PIK3R5;ADCY5;PPP1CA;CACNG6;PPP3R1;PLCB3;CACNG8;CACNG1;MYL9;PLCB2;PPP1R12C
8,KEGG_2021_Human,Vascular smooth muscle contraction,21/133,0.1799782146320509,0.999995789583929,0,0,1.2807942451714625,2.196458982010077,PTGIR;RAMP2;PPP1R12A;AVPR1B;PLA2G4D;ROCK2;PRKCD;PLA2G4C;IRAG1;BRAF;MYLK3;ADCY5;PPP1CA;ACTA2;NPPC;PLCB3;KCNMA1;MYH11;MYL9;PLCB2;PPP1R12C
9,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,23/150,0.2049492605210593,0.999995789583929,0,0,1.2369970025936108,1.960631392376444,TNNC1;CAMK2A;CACNA2D2;ATP2B3;ATP1B2;SLC8A2;PIK3R5;ADCY5;PPP1CA;CACNG6;PLCB3;CACNG8;CREB3L3;PPP1R1A;PPP2R2B;AKT2;FXYD2;TNNT2;CACNG1;PLCB2;SCN4B;SCN1B;RAPGEF3
10,KEGG_2021_Human,alpha-Linolenic acid metabolism,5/25,0.208411998582337,0.999995789583929,0,0,1.7060321190755974,2.675465073924826,FADS2;PLA2G4D;PLA2G4C;PLAAT3;ACOX3
11,KEGG_2021_Human,Inositol phosphate metabolism,12/73,0.218161975087717,0.999995789583929,0,0,1.3429745148287895,2.0447021835498584,FIG4;MIOX;PLCB3;ISYNA1;MTMR3;IMPA1;PIP5KL1;INPP5D;PIP4K2B;PI4KB;PLCH2;PLCB2
12,KEGG_2021_Human,B cell receptor signaling pathway,13/81,0.2315075037958641,0.999995789583929,0,0,1.305108055009823,1.9095597047202493,LILRA6;CD72;LILRA1;LILRB2;LILRA2;LILRB3;LILRB5;LILRA5;CD79B;PPP3R1;AKT2;INPP5D;RAC3
13,KEGG_2021_Human,Gastric acid secretion,12/76,0.2614695858202516,0.999995789583929,0,0,1.2798016496465043,1.716773680771295,ATP4B;ATP4A;PLCB3;KCNJ10;CCKBR;CAMK2A;ATP1B2;SSTR2;PLCB2;MYLK3;ACTG1;ADCY5
14,KEGG_2021_Human,Glycerophospholipid metabolism,15/98,0.2676443796636308,0.999995789583929,0,0,1.233648712032558,1.626067582242919,ACHE;CHKB;PLA2G4D;PNPLA7;PLA2G4C;PLD4;PLAAT3;PLD1;DGKZ;PLD2;PTDSS2;ETNK2;PLPP3;DGKI;LPIN3
15,KEGG_2021_Human,Focal adhesion,29/201,0.2711593048229447,0.999995789583929,0,0,1.151365095129061,1.502587624405318,LAMA5;SHC2;TNXB;ITGB4;ROCK2;MYLK3;MYL12B;ACTG1;COMP;MAPK8;CCND2;AKT2;CAPN2;MYL10;RAC3;PPP1R12A;BRAF;LAMB1;PGF;PPP1CA;COL6A2;ITGA11;RAPGEF1;COL6A3;TLN2;COL9A2;MYL9;PPP1R12C;VCL
16,KEGG_2021_Human,Cocaine addiction,8/49,0.2857192731824177,0.999995789583929,0,0,1.331496891439503,1.66802675567087,GRIN3B;CREB3L3;PPP1R1B;GRIN2C;SLC6A3;ADCY5;GRIN1;CDK5R1
17,KEGG_2021_Human,Ether lipid metabolism,8/49,0.2857192731824177,0.999995789583929,0,0,1.331496891439503,1.66802675567087,PLA2G4D;PLA2G4C;PLD4;PLAAT3;PLPP3;PLD1;PAFAH1B2;PLD2
18,KEGG_2021_Human,Glutamatergic synapse,17/114,0.2863563867264662,0.999995789583929,0,0,1.1963185205921851,1.496018007000968,PLA2G4D;PLA2G4C;GRIK1;PLD1;GRIN2C;PLD2;ADCY5;GRIN1;PPP3R1;GRIN3B;PLCB3;GNB1;SLC17A7;SLC38A3;PLCB2;SHANK3;SHANK1
19,KEGG_2021_Human,Hippo signaling pathway,23/163,0.3397001387494056,0.999995789583929,0,0,1.1212905043674275,1.2106483820485567,APC2;PATJ;WNT5B;WNT3A;ITGB2;WNT9B;BMP8B;WNT9A;AFP;LIMD1;WTIP;YWHAZ;ACTG1;STK3;GDF7;PPP1CA;CCND2;DLG3;PPP2R2B;DVL1;CCN2;WNT1;LLGL2
20,KEGG_2021_Human,Sphingolipid signaling pathway,17/119,0.3513459860418256,0.999995789583929,0,0,1.1373475009838647,1.1896470903381966,CERS4;ROCK2;NOS3;SPHK1;PLD1;PLD2;SGPL1;PLCB3;MAPK8;PPP2R2B;AKT2;ADORA1;RAC3;S1PR5;PLCB2;S1PR4;CERS1
21,KEGG_2021_Human,Long-term potentiation,10/67,0.3517221174650844,0.999995789583929,0,0,1.1970172684458398,1.2507799274854892,PLCB3;PPP3R1;PPP1R1A;CAMK2A;BRAF;GRIN2C;PLCB2;RAPGEF3;GRIN1;PPP1CA
22,KEGG_2021_Human,Thyroid hormone synthesis,11/75,0.3622050796182332,0.999995789583929,0,0,1.17269091087554,1.190920050166092,DUOX1;PLCB3;TPO;CREB3L3;FXYD2;DUOXA2;ATP1B2;PLCB2;ASGR1;ASGR2;ADCY5
23,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,14/98,0.371946673840945,0.999995789583929,0,0,1.137185534591195,1.124681935000759,NTRK1;PLA2G4D;PRKCD;PLA2G4C;CAMK2A;TRPV1;NGF;ADCY5;PPP1CA;PLCB3;MAPK8;TRPM8;PLCB2;ASIC1
24,KEGG_2021_Human,Amphetamine addiction,10/69,0.3876466557841943,0.999995789583929,0,0,1.156307373014395,1.095787442177191,PPP3R1;GRIN3B;CREB3L3;CAMK2A;PPP1R1B;GRIN2C;SLC6A3;ADCY5;GRIN1;PPP1CA
25,KEGG_2021_Human,Carbohydrate digestion and absorption,7/47,0.3953655957343896,0.999995789583929,0,0,1.1937867502940025,1.107767709823397,PLCB3;AKT2;FXYD2;ATP1B2;SLC2A5;PLCB2;HK1
26,KEGG_2021_Human,Nicotine addiction,6/40,0.4055531937081589,0.999995789583929,0,0,1.2037617554858937,1.0863988766801262,GRIN3B;CHRNA4;SLC17A7;GRIN2C;GABRD;GRIN1
27,KEGG_2021_Human,cAMP signaling pathway,29/216,0.4195828165514365,0.999995789583929,0,0,1.058089794744599,0.918945014107864,HCN4;ADCYAP1R1;CHRM1;ROCK2;CAMK2A;PLD1;ADCY5;PLD2;MAPK8;CREB3L3;AKT2;ADORA1;RAC3;PPP1R12A;ATP2B3;BRAF;ATP1B2;GRIN2C;SSTR2;GRIN1;PPP1CA;POMC;GRIN3B;FXYD2;PPP1R1B;ACOX3;MYL9;RAPGEF3;HCN2
28,KEGG_2021_Human,Maturity onset diabetes of the young,4/26,0.4300548848924629,0.999995789583929,0,0,1.2401224460738949,1.046467949745776,PAX4;HES1;HNF1A;FOXA3
29,KEGG_2021_Human,Neuroactive ligand-receptor interaction,45/341,0.4348357106158069,0.999995789583929,0,0,1.037268366655553,0.8638236070885795,ADCYAP1R1;CHRNA3;CHRM1;CHRNA2;CHRNA4;OPRL1;GRIK1;PTH1R;CRHR1;CHRND;C5;P2RY6;CNR1;P2RY1;PPY;ADORA1;TAC4;TAC3;PRLH;S1PR5;GABRD;S1PR4;NTSR1;UTS2R;SLURP2;PTGIR;AVPR1B;GCGR;TRPV1;GRIN2C;SSTR2;PRLR;ADRA2B;SLURP1;GRIN1;HCRTR1;POMC;UTS2B;GH1;PYY;GRIN3B;CCKBR;P2RX1;MC5R;NMUR1
30,KEGG_2021_Human,Collecting duct acid secretion,4/27,0.4599626037963559,0.999995789583929,0,0,1.1861359844744817,0.9211651723485336,ATP4B;ATP4A;ATP6V0A4;ATP6V1C2
31,KEGG_2021_Human,Cholinergic synapse,15/113,0.480743606359053,0.999995789583929,0,0,1.0439220910542746,0.7645906642756826,KCNJ4;ACHE;CHRNA3;CHRM1;CHRNA4;KCNJ12;CAMK2A;PIK3R5;ADCY5;PLCB3;CREB3L3;AKT2;GNB1;KCNQ3;PLCB2
32,KEGG_2021_Human,VEGF signaling pathway,8/59,0.487623205492015,0.999995789583929,0,0,1.0698039215686277,0.7683463257092652,SHC2;PPP3R1;PLA2G4D;NOS3;AKT2;SPHK1;PLA2G4C;RAC3
33,KEGG_2021_Human,"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.4955709538919639,0.999995789583929,0,0,1.7049276495893626,1.196935486617833,HK1
34,KEGG_2021_Human,MAPK signaling pathway,38/294,0.4987163687862082,0.999995789583929,0,0,1.0123201884920634,0.7042891178007847,RASGRP2;RASGRP4;CACNA1G;STK3;CACNG6;PPP3R1;CACNG8;MAPK8;AKT2;MKNK2;MAP3K20;RAC3;CACNG1;MAP3K6;MAP3K4;FGF22;NTRK1;MAP4K2;HSPA8;MEF2C;DUSP2;PLA2G4D;PLA2G4C;IGF2;CACNA2D2;FLT3LG;BRAF;DUSP8;NGF;PGF;NR4A1;EFNA3;EFNA2;TAOK1;PTPN7;FGFR4;MAP3K14;EPHA2
35,KEGG_2021_Human,Mineral absorption,8/60,0.5074851011558112,0.999995789583929,0,0,1.0491704374057316,0.7116396398254503,SLC9A3;SLC6A19;FXYD2;ATP2B3;ATP1B2;CLCN2;SLC39A4;SLC8A2
36,KEGG_2021_Human,Linoleic acid metabolism,4/29,0.5179686226643668,0.999995789583929,0,0,1.0911198120595145,0.7177829255463263,PLA2G4D;PLA2G4C;CYP1A2;PLAAT3
37,KEGG_2021_Human,Cushing syndrome,20/155,0.5194319640043188,0.999995789583929,0,0,1.0102442868400314,0.6617296484434587,APC2;FH;WNT5B;WNT3A;CAMK2A;AIP;WNT9B;BRAF;WNT9A;CRHR1;CACNA1G;ADCY5;POMC;NR4A1;PLCB3;CREB3L3;CYP21A2;DVL1;WNT1;PLCB2
38,KEGG_2021_Human,ABC transporters,6/45,0.5230637850273763,0.999995789583929,0,0,1.0491319025801784,0.6798918834273466,ABCA2;ABCG5;ABCC2;ABCA7;ABCB9;ABCG4
39,KEGG_2021_Human,Glycosphingolipid biosynthesis,6/45,0.5230637850273763,0.999995789583929,0,0,1.0491319025801784,0.6798918834273466,FUT6;B3GNT5;FUT1;ST6GALNAC4;ST6GALNAC5;ST3GAL3
40,KEGG_2021_Human,Arachidonic acid metabolism,8/61,0.5270947806442732,0.999995789583929,0,0,1.0293155752867185,0.6591478557022225,PLA2G4D;PRXL2B;PLA2G4C;PLAAT3;ALOX12B;GGT1;LTC4S;PTGES
41,KEGG_2021_Human,GnRH signaling pathway,12/93,0.5336455048793075,0.999995789583929,0,0,1.0102120974076982,0.6344369462558839,PLCB3;MAPK8;PLA2G4D;MMP2;PLA2G4C;PRKCD;CAMK2A;PLD1;PLCB2;MAP3K4;ADCY5;PLD2
42,KEGG_2021_Human,Caffeine metabolism,1/6,0.560103424115849,0.999995789583929,0,0,1.3638639030113413,0.7905416527696556,CYP1A2
43,KEGG_2021_Human,Mannose type O-glycan biosynthesis,3/23,0.5785101707527279,0.999995789583929,0,0,1.0228180039138943,0.559787425429017,POMT2;LARGE2;ST3GAL3
44,KEGG_2021_Human,ECM-receptor interaction,11/88,0.5806228357258961,0.999995789583929,0,0,0.9739749845756912,0.5295052958587609,COMP;LAMA5;GP9;TNXB;ITGB4;COL6A2;ITGA11;COL6A3;LAMB1;COL9A2;HSPG2
45,KEGG_2021_Human,Apelin signaling pathway,17/137,0.5919407983489946,0.999995789583929,0,0,0.965741833923652,0.5063854286893295,MEF2A;RYR1;NOTCH3;HDAC5;MEF2C;NOS3;SPHK1;MYLK3;SLC8A2;PIK3R5;ADCY5;ACTA2;PLCB3;AKT2;GNB1;CCN2;PLCB2
46,KEGG_2021_Human,Cortisol synthesis and secretion,8/65,0.6022846909659252,0.999995789583929,0,0,0.9568627450980391,0.4851533686205812,POMC;NR4A1;PLCB3;CREB3L3;CYP21A2;PLCB2;ADCY5;CACNA1G
47,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",13/106,0.6083493116302182,0.999995789583929,0,0,0.9528994232841118,0.4735967653447777,MEF2A;MEF2C;BRAF;PTH1R;PLD1;PLD2;ADCY5;LRP6;MMP25;PLCB3;CREB3L3;MMP17;PLCB2
48,KEGG_2021_Human,Aldosterone synthesis and secretion,12/98,0.6098632302655664,0.999995789583929,0,0,0.9512048082719816,0.4703903341128315,POMC;NR4A1;PLCB3;DAGLA;CREB3L3;CYP21A2;CAMK2A;ATP2B3;ATP1B2;PLCB2;CACNA1G;ADCY5
49,KEGG_2021_Human,Hypertrophic cardiomyopathy,11/90,0.6116975961595196,0.999995789583929,0,0,0.9492080531575992,0.466552124857846,CACNG6;CACNG8;ACE;ITGB4;TNNC1;TNNT2;ITGA11;CACNA2D2;CACNG1;ACTG1;SLC8A2
50,KEGG_2021_Human,Tryptophan metabolism,5/42,0.6376184774762845,0.999995789583929,0,0,0.9212796815617028,0.4145898345380682,AOC1;CYP1A2;KYAT3;ACAT2;ACMSD
51,KEGG_2021_Human,Notch signaling pathway,7/59,0.6428824139283192,0.999995789583929,0,0,0.9176642643910382,0.4054180544213494,NOTCH2;NOTCH3;KAT2A;DVL1;DTX1;HES1;DLL3
52,KEGG_2021_Human,Propanoate metabolism,4/34,0.6481365583216884,0.999995789583929,0,0,0.9090054815974942,0.3941937419292266,DBT;ECHDC1;ACOX3;ACAT2
53,KEGG_2021_Human,Melanogenesis,12/101,0.6525987306336608,0.999995789583929,0,0,0.918982850384388,0.3922153005494107,POMC;PLCB3;CREB3L3;WNT5B;WNT3A;DVL1;CAMK2A;WNT9B;WNT9A;WNT1;PLCB2;ADCY5
54,KEGG_2021_Human,Selenocompound metabolism,2/17,0.6590426630412306,0.999995789583929,0,0,0.9090766823161188,0.3790549838261659,TXNRD3;KYAT3
55,KEGG_2021_Human,Long-term depression,7/60,0.6607650641807871,0.999995789583929,0,0,0.9002980703090908,0.3730447419312591,RYR1;PLCB3;PLA2G4D;PLA2G4C;BRAF;PLCB2;CRHR1
56,KEGG_2021_Human,Folate biosynthesis,3/26,0.663861971721384,0.999995789583929,0,0,0.8892538075385008,0.3643104113824766,ALPP;ALPI;ALPG
57,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,9/77,0.6650624168138203,0.999995789583929,0,0,0.9021184778344448,0.3679510174137224,CACNG6;CACNG8;ACTN3;ITGB4;ITGA11;CACNA2D2;CACNG1;ACTG1;SLC8A2
58,KEGG_2021_Human,Renin secretion,8/69,0.6709217646600106,0.999995789583929,0,0,0.893911925425908,0.356762702286894,PLCB3;ADCYAP1R1;PPP3R1;ACE;KCNMA1;ADORA1;PLCB2;ADCY5
59,KEGG_2021_Human,Biosynthesis of unsaturated fatty acids,3/27,0.6893493680328885,0.999995789583929,0,0,0.8521526418786692,0.3170068084549222,FADS2;ACOX3;HACD3
60,KEGG_2021_Human,Mucin type O-glycan biosynthesis,4/36,0.6931392885116487,0.999995789583929,0,0,0.8520947533281128,0.3123134385064123,ST6GALNAC1;ST6GALNAC2;GALNT16;ST6GALNAC4
61,KEGG_2021_Human,Dilated cardiomyopathy,11/96,0.6975127275221661,0.999995789583929,0,0,0.881900274833137,0.3176909205251417,CACNG6;CACNG8;ITGB4;TNNC1;TNNT2;ITGA11;CACNA2D2;CACNG1;ACTG1;SLC8A2;ADCY5
62,KEGG_2021_Human,Breast cancer,17/147,0.7086344789830895,0.999995789583929,0,0,0.8909393636666364,0.3068532638998389,NOTCH2;APC2;NOTCH3;SHC2;WNT5B;WNT3A;WNT9B;BRAF;WNT9A;ESR1;DLL3;LRP6;AKT2;DVL1;HES1;WNT1;FGF22
63,KEGG_2021_Human,Phosphatidylinositol signaling system,11/97,0.7106148461503196,0.999995789583929,0,0,0.8715954017950895,0.297758520447114,PLCB3;MTMR3;IMPA1;PPIP5K2;INPP5D;PIP4K2B;PI4KB;DGKZ;PLCB2;DGKI;IP6K3
64,KEGG_2021_Human,Basal cell carcinoma,7/63,0.7110325941285356,0.999995789583929,0,0,0.851920815366523,0.29053652556215,APC2;WNT5B;WNT3A;DVL1;WNT9B;WNT9A;WNT1
65,KEGG_2021_Human,Lysine degradation,7/63,0.7110325941285356,0.999995789583929,0,0,0.851920815366523,0.29053652556215,KMT2E;KMT5C;PRDM6;NSD2;KMT5B;AASS;ACAT2
66,KEGG_2021_Human,Leukocyte transendothelial migration,13/114,0.712832309676434,0.999995789583929,0,0,0.8770176428251862,0.2968784319294308,ROCK2;MMP2;CTNND1;NCF4;ITGB2;ACTG1;MYL12B;CLDN9;MYL10;CLDN16;MYL9;VCL;RAPGEF3
67,KEGG_2021_Human,Type II diabetes mellitus,5/46,0.7172685174663692,0.999995789583929,0,0,0.8312076657781854,0.2762144693136099,MAPK8;PRKCD;SLC2A4;CACNA1G;HK1
68,KEGG_2021_Human,Choline metabolism in cancer,11/98,0.7233535451735366,0.999995789583929,0,0,0.8615274223901006,0.2790118405343182,MAPK8;CHKB;PLA2G4D;AKT2;PLA2G4C;RAC3;PLPP3;PLD1;DGKZ;DGKI;PLD2
69,KEGG_2021_Human,Wnt signaling pathway,19/166,0.7324074670325145,0.999995789583929,0,0,0.8804285794664459,0.2741815459043586,APC2;WNT5B;WNT3A;ROCK2;CTNNBIP1;SIAH1;CAMK2A;WNT9B;WNT9A;LRP6;PPP3R1;PLCB3;MAPK8;CCND2;DVL1;RAC3;WNT1;PLCB2;RSPO4
70,KEGG_2021_Human,Synthesis and degradation of ketone bodies,1/10,0.7455976993041206,0.999995789583929,0,0,0.7575283535393039,0.222386917967483,ACAT2
71,KEGG_2021_Human,Regulation of actin cytoskeleton,25/218,0.7506316224361685,0.999995789583929,0,0,0.8820870212674561,0.2530180737197118,CHRM1;ITGB4;ROCK2;ITGB2;MYLK3;MYL12B;ACTG1;FGD3;TMSB4X;MYL10;RAC3;PIP4K2B;MYH11;FGF22;APC2;PPP1R12A;INSRR;LIMK1;BRAF;PPP1CA;ITGA11;FGFR4;MYL9;PPP1R12C;VCL
72,KEGG_2021_Human,Rap1 signaling pathway,24/210,0.7531910432469889,0.999995789583929,0,0,0.8786821804109275,0.2490504909995954,CTNND1;ITGB2;BRAF;RASGRP2;NGF;PGF;ADCY5;GRIN1;ACTG1;PLCB3;EFNA3;EFNA2;CNR1;AKT2;P2RY1;RAPGEF1;RAC3;TLN2;FGFR4;PLCB2;SKAP1;RAPGEF3;FGF22;EPHA2
73,KEGG_2021_Human,Legionellosis,6/57,0.7535144483105262,0.999995789583929,0,0,0.8017241379310345,0.2268936121867345,HSPA8;APAF1;ITGB2;EEF1A2;TLR5;CXCL2
74,KEGG_2021_Human,Citrate cycle (TCA cycle),3/30,0.7570155708798416,0.999995789583929,0,0,0.7573385518590998,0.2108214357917649,FH;PC;DLAT
75,KEGG_2021_Human,Alcoholism,21/186,0.76197653698833,0.999995789583929,0,0,0.8667287777260185,0.2356111306805829,H4C8;HDAC5;SHC2;HDAC10;BRAF;GRIN2C;HDAC8;H2AC16;MACROH2A1;SLC6A3;CAMKK1;ADCY5;GRIN1;PPP1CA;GRIN3B;CREB3L3;GNB1;PPP1R1B;H4C2;H3C7;H3-3A
76,KEGG_2021_Human,Osteoclast differentiation,14/127,0.7629233453698235,0.999995789583929,0,0,0.8439291478822285,0.2283653011727739,LILRA6;SPI1;NCF4;LILRA1;LILRB2;LILRA2;LILRB3;LILRB5;FOSL2;LILRA5;PPP3R1;MAPK8;AKT2;MAP3K14
77,KEGG_2021_Human,Sphingolipid metabolism,5/49,0.7682614989362826,0.999995789583929,0,0,0.7744008830965353,0.2041515182866852,CERS4;SGPL1;SPHK1;PLPP3;CERS1
78,KEGG_2021_Human,Galactose metabolism,3/31,0.7767457906875935,0.999995789583929,0,0,0.7302488118535085,0.1844916297577427,GAA;HK1;GALK1
79,KEGG_2021_Human,Taurine and hypotaurine metabolism,1/11,0.7781518553566035,0.999995789583929,0,0,0.6817364098552992,0.1710023890837803,GGT1
80,KEGG_2021_Human,Arginine and proline metabolism,5/50,0.7836136245846422,0.999995789583929,0,0,0.7571484528006267,0.1846224774756575,AOC1;NOS3;AZIN2;PYCR1;SRM
81,KEGG_2021_Human,Cholesterol metabolism,5/50,0.7836136245846422,0.999995789583929,0,0,0.7571484528006267,0.1846224774756575,ABCG5;LRP1;ANGPTL8;APOC3;LDLRAP1
82,KEGG_2021_Human,Malaria,5/50,0.7836136245846422,0.999995789583929,0,0,0.7571484528006267,0.1846224774756575,COMP;CSF3;LRP1;SDC2;ITGB2
83,KEGG_2021_Human,Insulin secretion,9/86,0.7866911406697753,0.999995789583929,0,0,0.7962633678600725,0.1910391561393958,PLCB3;ADCYAP1R1;CREB3L3;FXYD2;KCNMA1;CAMK2A;ATP1B2;PLCB2;ADCY5
84,KEGG_2021_Human,Arginine biosynthesis,2/22,0.791981656944653,0.999995789583929,0,0,0.6816118935837245,0.1589635136074081,NOS3;GPT
85,KEGG_2021_Human,Histidine metabolism,2/22,0.791981656944653,0.999995789583929,0,0,0.6816118935837245,0.1589635136074081,ALDH3B2;AOC1
86,KEGG_2021_Human,Ras signaling pathway,26/232,0.7931976466136341,0.999995789583929,0,0,0.8591696191659381,0.199054865394301,SHC2;RASAL2;PLD1;RASGRP2;RASGRP4;PLD2;MAPK8;AKT2;RAC3;FGF22;NTRK1;PLA2G4D;PLA2G4C;IGF2;FLT3LG;PLAAT3;NGF;PGF;GRIN1;ZAP70;EFNA3;EFNA2;GNB1;RIN1;FGFR4;EPHA2
87,KEGG_2021_Human,Synaptic vesicle cycle,8/78,0.7965100521836628,0.999995789583929,0,0,0.7785770308123249,0.1771383652409014,SLC6A9;SLC6A12;ATP6V0A4;SLC17A7;AP2A2;SLC6A3;CPLX3;ATP6V1C2
88,KEGG_2021_Human,Cardiac muscle contraction,9/87,0.7979403892156341,0.999995789583929,0,0,0.7860095965235235,0.1774191743996782,CACNG6;CACNG8;TNNC1;TNNT2;FXYD2;CACNA2D2;ATP1B2;CACNG1;SLC8A2
89,KEGG_2021_Human,Phospholipase D signaling pathway,16/148,0.7992376646910527,0.999995789583929,0,0,0.8254059080180245,0.1849709256709188,SHC2;AVPR1B;PLA2G4D;SPHK1;PLA2G4C;PLD1;DGKZ;PIK3R5;PLD2;ADCY5;PLCB3;AKT2;PLPP3;PLCB2;DGKI;RAPGEF3
90,KEGG_2021_Human,Circadian entrainment,10/97,0.8101197324490973,0.999995789583929,0,0,0.782899366643209,0.1648576440157499,RYR1;ADCYAP1R1;PLCB3;GNB1;CAMK2A;GRIN2C;PLCB2;CACNA1G;ADCY5;GRIN1
91,KEGG_2021_Human,Fc gamma R-mediated phagocytosis,10/97,0.8101197324490973,0.999995789583929,0,0,0.782899366643209,0.1648576440157499,PLA2G4D;AKT2;INPP5D;SPHK1;PRKCD;PLA2G4C;LIMK1;PLPP3;PLD1;PLD2
92,KEGG_2021_Human,Protein export,2/23,0.8123122397010881,0.999995789583929,0,0,0.6491169237648111,0.1349322472216025,SRP72;SRP14
93,KEGG_2021_Human,Renin-angiotensin system,2/23,0.8123122397010881,0.999995789583929,0,0,0.6491169237648111,0.1349322472216025,ACE;KLK1
94,KEGG_2021_Human,Fat digestion and absorption,4/43,0.8176394836059921,0.999995789583929,0,0,0.6988735618336245,0.14070684799077,ABCG5;MOGAT3;PLPP3;ACAT2
95,KEGG_2021_Human,Hepatocellular carcinoma,18/168,0.8216168717737118,0.999995789583929,0,0,0.8169448818897638,0.1605142170351316,APC2;SHC2;WNT5B;ACTL6B;TXNRD3;WNT3A;MGST3;IGF2;WNT9B;BRAF;WNT9A;ACTG1;SMARCA4;LRP6;AKT2;DPF1;DVL1;WNT1
96,KEGG_2021_Human,Insulin resistance,11/108,0.8303424543714744,0.999995789583929,0,0,0.7722649245726729,0.1435772302312005,SREBF1;PTPN1;MAPK8;CREB3L3;PPP1R3C;NOS3;AKT2;PRKCD;SLC2A4;SLC27A3;PPP1CA
97,KEGG_2021_Human,Nicotinate and nicotinamide metabolism,3/35,0.8428427969202902,0.999995789583929,0,0,0.638820939334638,0.1092222944068614,NMRK2;NT5C1A;ASPDH
98,KEGG_2021_Human,GnRH secretion,6/64,0.8438614688362306,0.999995789583929,0,0,0.7046805750729651,0.1196314608965392,TRPC5;PLCB3;AKT2;PLCB2;HCN2;CACNA1G
99,KEGG_2021_Human,Calcium signaling pathway,26/240,0.8441534445639954,0.999995789583929,0,0,0.8266672572381922,0.1400547888877682,RET;RYR1;CHRM1;CAMK2A;MYLK3;SLC8A2;CACNA1G;PPP3R1;NTSR1;FGF22;NTRK1;AVPR1B;NOS3;SPHK1;TNNC1;ATP2B3;PHKB;GRIN2C;NGF;GRIN1;PLCB3;CCKBR;P2RX1;PPIF;FGFR4;PLCB2
100,KEGG_2021_Human,Neutrophil extracellular trap formation,20/189,0.8473218492597792,0.999995789583929,0,0,0.8054145042688414,0.1334367815533843,GSDMD;H4C8;FGB;HDAC5;HDAC10;NCF4;ITGB2;HDAC8;H2AC16;MACROH2A1;ACTG1;C5;PLCB3;AKT2;PPIF;H4C2;PLCB2;ELANE;H3C7;H3-3A
101,KEGG_2021_Human,Neurotrophin signaling pathway,12/119,0.8479477688090027,0.999995789583929,0,0,0.7635947170199177,0.1259444403429631,NTRK1;SHC2;MAPK8;KIDINS220;AKT2;PRKCD;CAMK2A;ARHGDIG;MATK;RAPGEF1;BRAF;NGF
102,KEGG_2021_Human,Estrogen signaling pathway,14/137,0.8499658645658664,0.999995789583929,0,0,0.7748696119036662,0.1259620986995647,HSPA8;SHC2;NOS3;MMP2;PRKCD;ESR1;ADCY5;POMC;PLCB3;KRT19;CREB3L3;KRT16;AKT2;PLCB2
103,KEGG_2021_Human,Insulin signaling pathway,14/137,0.8499658645658664,0.999995789583929,0,0,0.7748696119036662,0.1259620986995647,SREBF1;PTPN1;SHC2;BRAF;PHKB;SLC2A4;HK1;PPP1CA;RPTOR;MAPK8;PPP1R3C;AKT2;MKNK2;RAPGEF1
104,KEGG_2021_Human,Starch and sucrose metabolism,3/36,0.8564521782576515,0.999995789583929,0,0,0.6194271481942715,0.0959844466638497,GAA;GYG1;HK1
105,KEGG_2021_Human,Tyrosine metabolism,3/36,0.8564521782576515,0.999995789583929,0,0,0.6194271481942715,0.0959844466638497,PNMT;ALDH3B2;TPO
106,KEGG_2021_Human,Axon guidance,19/182,0.8577931024657899,0.999995789583929,0,0,0.7932715889788019,0.1216817915480449,SEMA6B;SEMA5B;TRPC5;WNT5B;ROCK2;CAMK2A;LIMK1;LRRC4;UNC5D;MYL12B;GDF7;EFNB1;PPP3R1;EFNA3;EFNA2;RAC3;PLXNC1;MYL9;EPHA2
107,KEGG_2021_Human,Thyroid hormone signaling pathway,12/121,0.8630404694160159,0.999995789583929,0,0,0.7494973226575956,0.1103962301375348,NOTCH2;NOTCH3;KAT2A;PLCB3;MED24;AKT2;FXYD2;ATP1B2;ESR1;PLCB2;ACTG1;MED13L
108,KEGG_2021_Human,Other types of O-glycan biosynthesis,4/47,0.8678721650472312,0.999995789583929,0,0,0.6337163774107192,0.0898044867927113,POMT2;GALNT16;XXYLT1;ST3GAL3
109,KEGG_2021_Human,Pyruvate metabolism,4/47,0.8678721650472312,0.999995789583929,0,0,0.6337163774107192,0.0898044867927113,FH;PC;DLAT;ACAT2
110,KEGG_2021_Human,Aldosterone-regulated sodium reabsorption,3/37,0.8690179196153734,0.999995789583929,0,0,0.601174168297456,0.0843997630680722,FXYD2;SFN;ATP1B2
111,KEGG_2021_Human,Thyroid cancer,3/37,0.8690179196153734,0.999995789583929,0,0,0.601174168297456,0.0843997630680722,RET;NTRK1;BRAF
112,KEGG_2021_Human,Fatty acid elongation,2/27,0.8769295301727815,0.999995789583929,0,0,0.5451330203442879,0.071591579881288,THEM5;HACD3
113,KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,4/48,0.8783974538788791,0.999995789583929,0,0,0.6192781376806435,0.0802931923708396,CHIT1;CYB5R4;HK1;GALK1
114,KEGG_2021_Human,Fc epsilon RI signaling pathway,6/68,0.882073325718491,0.999995789583929,0,0,0.6590656284760845,0.0826996148355837,MAPK8;PLA2G4D;AKT2;INPP5D;PLA2G4C;RAC3
115,KEGG_2021_Human,Adipocytokine signaling pathway,6/69,0.8902901282452563,0.999995789583929,0,0,0.6485669502910882,0.0753685920083784,POMC;STK11;MAPK8;AKT2;SLC2A4;ACSL3
116,KEGG_2021_Human,Glucagon signaling pathway,10/107,0.8919232361840913,0.999995789583929,0,0,0.7017834889705288,0.0802666326587624,PPP3R1;PLCB3;CREB3L3;AKT2;GCGR;CAMK2A;PHKB;PPP4R3B;SIK2;PLCB2
117,KEGG_2021_Human,JAK-STAT signaling pathway,16/162,0.8946176997973673,0.999995789583929,0,0,0.7456538374486705,0.0830351188105338,CNTFR;IL11;CSF3;IL11RA;IL24;MPL;OSM;IL20RB;PRLR;PIAS1;GH1;CCND2;THPO;AKT2;IL7R;IL12RB1
118,KEGG_2021_Human,PI3K-Akt signaling pathway,38/354,0.8963467716619861,0.999995789583929,0,0,0.8172443238898935,0.0894293456261018,LAMA5;CSF3;TNXB;CHRM1;PKN3;ITGB4;PIK3R5;RPTOR;COMP;STK11;CCND2;CREB3L3;AKT2;FGF22;NTRK1;NOS3;IGF2;OSM;FLT3LG;LAMB1;NGF;PRLR;YWHAZ;PGF;GH1;NR4A1;EFNA3;EFNA2;PPP2R2B;CDC37;COL6A2;GNB1;ITGA11;COL6A3;COL9A2;FGFR4;IL7R;EPHA2
119,KEGG_2021_Human,Vibrio cholerae infection,4/50,0.8972806303138966,0.999995789583929,0,0,0.5922849068809369,0.0641957541257555,KDELR1;ATP6V0A4;ACTG1;ATP6V1C2
120,KEGG_2021_Human,Prolactin signaling pathway,6/70,0.8980145780131016,0.999995789583929,0,0,0.638396355799373,0.0686716428781858,SHC2;MAPK8;CCND2;AKT2;PRLR;ESR1
121,KEGG_2021_Human,Hematopoietic cell lineage,9/99,0.9003394532142356,0.999995789583929,0,0,0.6807375441349549,0.0714661531439383,GP9;IL11;FCER2;CSF3;THPO;IL11RA;CD7;FLT3LG;IL7R
122,KEGG_2021_Human,Nitrogen metabolism,1/17,0.9024562653086624,0.999995789583929,0,0,0.4259385999217833,0.0437162292618395,CA7
123,KEGG_2021_Human,Phenylalanine metabolism,1/17,0.9024562653086624,0.999995789583929,0,0,0.4259385999217833,0.0437162292618395,ALDH3B2
124,KEGG_2021_Human,Bile secretion,8/90,0.9032155974055426,0.999995789583929,0,0,0.6641798182687709,0.0676095185918695,SLC9A3;ABCG5;ABCC2;FXYD2;ATP1B2;SLC51A;SLC22A8;ADCY5
125,KEGG_2021_Human,Glycerolipid metabolism,5/61,0.9045793733863856,0.999995789583929,0,0,0.6080381623859885,0.0609772433852331,MOGAT3;PLPP3;DGKZ;DGKI;LPIN3
126,KEGG_2021_Human,Adherens junction,6/71,0.9052680279832398,0.999995789583929,0,0,0.6285387026766337,0.0625548213660382,PTPN1;CTNND1;RAC3;NECTIN3;VCL;ACTG1
127,KEGG_2021_Human,Bladder cancer,3/41,0.9100589779850476,0.999995789583929,0,0,0.5377690802348336,0.0506825151478488,MMP2;BRAF;UPK3A
128,KEGG_2021_Human,Glyoxylate and dicarboxylate metabolism,2/30,0.9111676827917604,0.999995789583929,0,0,0.4866420746702437,0.0452715015214949,AGXT;ACAT2
129,KEGG_2021_Human,beta-Alanine metabolism,2/30,0.9111676827917604,0.999995789583929,0,0,0.4866420746702437,0.0452715015214949,ALDH3B2;ACOX3
130,KEGG_2021_Human,Purine metabolism,12/129,0.9118943222782356,0.999995789583929,0,0,0.6979273672125204,0.0643706578740736,ENTPD2;GUCY2D;PDE6G;IMPDH1;NT5C1A;AK1;GMPS;ENTPD8;PDE5A;PDE6B;AK8;ADCY5
131,KEGG_2021_Human,Cell adhesion molecules,14/148,0.9148024031798158,0.999995789583929,0,0,0.7108091617384774,0.06329555836301,NLGN2;SDC2;ITGB2;LRRC4;NRXN2;VTCN1;MAG;CLDN9;NRCAM;CLDN16;PDCD1;SIGLEC1;NECTIN3;LRRC4B
132,KEGG_2021_Human,Fatty acid biosynthesis,1/18,0.914942494496958,0.999995789583929,0,0,0.4008603832616347,0.0356341082544237,ACSL3
133,KEGG_2021_Human,Other glycan degradation,1/18,0.914942494496958,0.999995789583929,0,0,0.4008603832616347,0.0356341082544237,MAN2B2
134,KEGG_2021_Human,Th1 and Th2 cell differentiation,8/92,0.915338892896572,0.999995789583929,0,0,0.6482913165266107,0.0573484382025051,NOTCH2;ZAP70;NOTCH3;MAPK8;PPP3R1;CD247;IL12RB1;DLL3
135,KEGG_2021_Human,Pancreatic secretion,9/102,0.917732736762554,0.999995789583929,0,0,0.6586643718599324,0.0565457219051318,CPA1;PLCB3;CTRB2;FXYD2;KCNMA1;ATP2B3;ATP1B2;PLCB2;ADCY5
136,KEGG_2021_Human,p53 signaling pathway,6/73,0.9184469471396932,0.999995789583929,0,0,0.609706171337669,0.0518683968182938,CCND2;APAF1;ZMAT3;SIAH1;SFN;PPM1D
137,KEGG_2021_Human,RNA polymerase,2/31,0.9204381232508576,0.999995789583929,0,0,0.4698343316604608,0.0389518508278086,POLR2B;POLR1C
138,KEGG_2021_Human,Glycosaminoglycan biosynthesis,4/53,0.920762758136488,0.999995789583929,0,0,0.5559266776405158,0.045893341364059,XYLT2;CHST14;B4GALT7;ST3GAL3
139,KEGG_2021_Human,Salivary secretion,8/93,0.9208963189594862,0.999995789583929,0,0,0.6406274509803922,0.0527927138990596,PLCB3;FXYD2;KCNMA1;ATP2B3;ATP1B2;BEST2;PLCB2;ADCY5
140,KEGG_2021_Human,Serotonergic synapse,10/113,0.9252281396368626,0.999995789583929,0,0,0.6606742771791315,0.0513442581335168,PLCB3;PLA2G4D;HTR3E;GNB1;PLA2G4C;BRAF;ALOX12B;PLCB2;RAPGEF3;ADCY5
141,KEGG_2021_Human,Glycosaminoglycan degradation,1/19,0.9258309144413162,0.999995789583929,0,0,0.3785686351192804,0.0291738841309249,SGSH
142,KEGG_2021_Human,Fatty acid degradation,3/43,0.925854878123745,0.999995789583929,0,0,0.5108219178082192,0.0393525843300766,ACSL3;ACOX3;ACAT2
143,KEGG_2021_Human,Dopaminergic synapse,12/132,0.925999858113536,0.999995789583929,0,0,0.6803613511390416,0.0523069954498524,PLCB3;MAPK8;CREB3L3;PPP2R2B;AKT2;GNB1;PPP1R1B;CAMK2A;PLCB2;SLC6A3;ADCY5;PPP1CA
144,KEGG_2021_Human,Tight junction,16/169,0.9262871046291684,0.999995789583929,0,0,0.7112509834775768,0.0544612304898266,PATJ;ROCK2;YBX3;ACTG1;MYL12B;STK11;MAPK8;DLG3;CLDN9;PPP2R2B;MYH11;ARHGEF2;CLDN16;MYL9;LLGL2;TUBA8
145,KEGG_2021_Human,Fanconi anemia pathway,4/54,0.9274468710932212,0.999995789583929,0,0,0.5447768206734535,0.0410324637347729,CENPX;REV1;HES1;FAAP100
146,KEGG_2021_Human,C-type lectin receptor signaling pathway,9/104,0.9278298026079626,0.999995789583929,0,0,0.644723420949392,0.0482942749716453,PPP3R1;MAPK8;CCL22;CLEC4M;AKT2;PRKCD;CARD9;MAP3K14;CCL17
147,KEGG_2021_Human,Complement and coagulation cascades,7/85,0.9301665505623042,0.999995789583929,0,0,0.6108615022766336,0.0442212551154777,FGB;C5;PROC;F12;ITGB2;SERPINF2;C1QC
148,KEGG_2021_Human,Spinocerebellar ataxia,13/143,0.9328434195156228,0.999995789583929,0,0,0.6802357563850687,0.0472885728263066,RYR1;BEAN1;KCNC3;GRIN2C;GRIN1;GRIN3B;PLCB3;MAPK8;PSMC6;AKT2;PPIF;ULK2;PLCB2
149,KEGG_2021_Human,Regulation of lipolysis in adipocytes,4/55,0.933617947238734,0.999995789583929,0,0,0.5340642129992169,0.0366837890452888,AKT2;ADORA1;PLAAT3;ADCY5
150,KEGG_2021_Human,Taste transduction,7/86,0.9350953612377464,0.999995789583929,0,0,0.6030943437420917,0.0404717099553779,HCN4;PLCB3;ENTPD2;HTR3E;P2RY1;TRPM5;PLCB2
151,KEGG_2021_Human,Pancreatic cancer,6/76,0.9352076380089293,0.999995789583929,0,0,0.5834751455441111,0.0390850754720726,MAPK8;AKT2;RAC3;BRAF;PLD1;PLD2
152,KEGG_2021_Human,One carbon pool by folate,1/20,0.935325919751112,0.999995789583929,0,0,0.3586233867813844,0.023977643256286,MTHFD2L
153,KEGG_2021_Human,Steroid biosynthesis,1/20,0.935325919751112,0.999995789583929,0,0,0.3586233867813844,0.023977643256286,MSMO1
154,KEGG_2021_Human,Base excision repair,2/33,0.936310418121754,0.999995789583929,0,0,0.4394719571911757,0.0289208646908971,LIG1;NEIL1
155,KEGG_2021_Human,Aminoacyl-tRNA biosynthesis,5/66,0.93642047728874,0.999995789583929,0,0,0.5580384375822722,0.0366579219223062,SARS1;IARS1;YARS1;WARS2;FARSB
156,KEGG_2021_Human,mTOR signaling pathway,14/154,0.938998097722582,0.999995789583929,0,0,0.6801100628930817,0.0428073689881453,WNT5B;WNT3A;WNT9B;BRAF;WNT9A;LRP6;RPTOR;STK11;AKT2;DVL1;ULK2;WNT1;LPIN3;ATP6V1C2
157,KEGG_2021_Human,Basal transcription factors,3/45,0.9390664623560424,0.999995789583929,0,0,0.486441151803187,0.030582079643102,GTF2IRD1;GTF2E2;GTF2H5
158,KEGG_2021_Human,Hedgehog signaling pathway,4/56,0.9393092354680416,0.999995789583929,0,0,0.5237636286970665,0.0327931182523604,CCND2;SPOP;SPOPL;MEGF8
159,KEGG_2021_Human,Pyrimidine metabolism,4/56,0.9393092354680416,0.999995789583929,0,0,0.5237636286970665,0.0327931182523604,NT5C1A;ENTPD8;TK2;UCKL1
160,KEGG_2021_Human,Bacterial invasion of epithelial cells,6/77,0.9400730395636692,0.999995789583929,0,0,0.575224071702945,0.0355475275341196,MAD2L2;SHC2;SEPTIN3;SEPTIN9;VCL;ACTG1
161,KEGG_2021_Human,Chemokine signaling pathway,18/192,0.9423752297223648,0.999995789583929,0,0,0.70328536519142,0.0417412176522356,SHC2;CCL22;ROCK2;PRKCD;BRAF;RASGRP2;CXCL2;PIK3R5;ADCY5;GRK1;PLCB3;AKT2;GNB1;CCR9;RAC3;CCR7;PLCB2;CCL17
162,KEGG_2021_Human,Pantothenate and CoA biosynthesis,1/21,0.9436057671755672,0.999995789583929,0,0,0.3406726632772781,0.0197749646215578,PANK3
163,KEGG_2021_Human,Glutathione metabolism,4/57,0.9445525976111364,0.999995789583929,0,0,0.5138517456893368,0.0293121103083613,MGST3;OPLAH;GGT1;SRM
164,KEGG_2021_Human,Nucleotide excision repair,3/47,0.9500683827836374,0.999995789583929,0,0,0.4642768190713396,0.0237808692435613,DDB1;LIG1;GTF2H5
165,KEGG_2021_Human,Relaxin signaling pathway,11/129,0.9503860905249948,0.999995789583929,0,0,0.6340593453248421,0.0322653562658747,ACTA2;SHC2;PLCB3;MAPK8;CREB3L3;NOS3;AKT2;MMP2;GNB1;PLCB2;ADCY5
166,KEGG_2021_Human,Terpenoid backbone biosynthesis,1/22,0.9508259173059764,0.999995789583929,0,0,0.3244315324878485,0.0163592282022882,ACAT2
167,KEGG_2021_Human,Fluid shear stress and atherosclerosis,12/139,0.951622318823282,0.999995789583929,0,0,0.6426013323354219,0.0318647023605982,MEF2A;NPPC;MEF2C;MAPK8;NOS3;AKT2;MGST3;SDC2;MMP2;RAC3;ARHGEF2;ACTG1
168,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,8/100,0.951667065652315,0.999995789583929,0,0,0.5916453537936914,0.0293101263936353,CCL22;IL24;CCR9;IL20RB;TNFRSF14;CCR7;CXCL2;CCL17
169,KEGG_2021_Human,Proteoglycans in cancer,19/205,0.9528029954652966,0.999995789583929,0,0,0.6942535161163272,0.0335651560343225,PPP1R12A;WNT5B;WNT3A;ROCK2;SDC2;MMP2;CAMK2A;IGF2;WNT9B;BRAF;WNT9A;HSPG2;ESR1;PPP1CA;ACTG1;AKT2;DROSHA;WNT1;PPP1R12C
170,KEGG_2021_Human,Gastric cancer,13/149,0.9529764415260034,0.999995789583929,0,0,0.65,0.0313073123759302,APC2;SHC2;WNT5B;WNT3A;WNT9B;BRAF;WNT9A;LRP6;AKT2;DVL1;RARB;WNT1;FGF22
171,KEGG_2021_Human,Central carbon metabolism in cancer,5/70,0.954638726853414,0.999995789583929,0,0,0.5235770887944801,0.0243056561249332,RET;NTRK1;AKT2;SLC16A3;HK1
172,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,5/70,0.954638726853414,0.999995789583929,0,0,0.5235770887944801,0.0243056561249332,MAPK8;ATP6V0A4;CXCL2;MAP3K14;ATP6V1C2
173,KEGG_2021_Human,Mismatch repair,1/23,0.9571219489820638,0.999995789583929,0,0,0.3096668681338216,0.013570985519108,LIG1
174,KEGG_2021_Human,Chagas disease,8/102,0.9582346688010488,0.999995789583929,0,0,0.5789904046725073,0.0247012209924534,PLCB3;MAPK8;ACE;PPP2R2B;AKT2;CD247;PLCB2;C1QC
175,KEGG_2021_Human,Small cell lung cancer,7/92,0.9587091014587106,0.999995789583929,0,0,0.5603292826342611,0.0236277328788642,LAMA5;ZBTB17;APAF1;AKT2;RARB;LAMB1;BIRC7
176,KEGG_2021_Human,African trypanosomiasis,2/37,0.9594891002913656,0.999995789583929,0,0,0.3891571652135032,0.0160933312553454,PLCB3;PLCB2
177,KEGG_2021_Human,"Alanine, aspartate and glutamate metabolism",2/37,0.9594891002913656,0.999995789583929,0,0,0.3891571652135032,0.0160933312553454,GPT;AGXT
178,KEGG_2021_Human,Peroxisome,6/82,0.959829060158046,0.999995789583929,0,0,0.5372257053291536,0.0220262929805005,PXMP2;FAR1;PEX10;ACSL3;ACOX3;AGXT
179,KEGG_2021_Human,Shigellosis,23/246,0.9621193605553654,0.999995789583929,0,0,0.7005722574539408,0.0270538311433355,CAST;ROCK2;PRKCD;FOXO6;SEPTIN3;SEPTIN9;MYL12B;ACTG1;HK1;RPTOR;PLCB3;MAPK8;AKT2;CAPN2;MYL10;TLN2;ARHGEF2;TLR5;MYL9;PLCB2;H3C7;H3-3A;VCL
180,KEGG_2021_Human,Cysteine and methionine metabolism,3/50,0.9631455997404452,0.999995789583929,0,0,0.4345671815797143,0.0163182952153148,KYAT3;MAT1A;SRM
181,KEGG_2021_Human,Primary immunodeficiency,2/38,0.963871710073869,0.999995789583929,0,0,0.3783255086071987,0.0139212717604693,ZAP70;IL7R
182,KEGG_2021_Human,TGF-beta signaling pathway,7/94,0.964655293295622,0.999995789583929,0,0,0.5473850687357223,0.0196973508980824,ZFYVE9;HJV;CHRD;BMP8B;NBL1;HAMP;GDF7
183,KEGG_2021_Human,Ovarian steroidogenesis,3/51,0.9667349268347116,0.999995789583929,0,0,0.4254892367906066,0.0143947009263669,PLA2G4D;PLA2G4C;ADCY5
184,KEGG_2021_Human,Various types of N-glycan biosynthesis,2/39,0.967796434995252,0.999995789583929,0,0,0.3680793469525864,0.0120485283389956,B4GALNT4;ST3GAL3
185,KEGG_2021_Human,Human papillomavirus infection,32/331,0.9678140558962496,0.999995789583929,0,0,0.7263271342585604,0.0237620109478798,NOTCH2;NOTCH3;LAMA5;PATJ;TNXB;ITGB4;COMP;CCND2;CREB3L3;AKT2;DVL1;ATP6V0A4;HES1;WNT1;HES2;ATP6V1C2;HES4;APC2;WNT5B;WNT3A;MX2;WNT9B;LAMB1;WNT9A;DLG3;NFX1;PPP2R2B;COL6A2;ITGA11;COL6A3;COL9A2;LLGL2
186,KEGG_2021_Human,Cytokine-cytokine receptor interaction,28/295,0.9679788556658164,0.999995789583929,0,0,0.7119065594883865,0.0231690240836256,CNTFR;CSF3;IL24;MPL;IL20RB;CXCL2;THPO;CCR9;CCR7;TNFRSF14;IL12RB1;CCL17;RELT;IL11;CCL22;GDF15;IL11RA;IL31RA;OSM;BMP8B;NGF;PRLR;GDF7;GH1;TNFRSF25;LTB;IL7R;IL17B
187,KEGG_2021_Human,Ferroptosis,2/41,0.9744496325512538,0.999995789583929,0,0,0.3491633562056097,0.0090372019905924,ACSL3;CP
188,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",9/119,0.9748335363795732,0.999995789583929,0,0,0.5563251185848282,0.0141799230931019,GH1;SHC2;PLCB3;MAPK8;CREB3L3;AKT2;SSTR2;PLCB2;ADCY5
189,KEGG_2021_Human,GABAergic synapse,6/89,0.9776167152979834,0.999995789583929,0,0,0.4917192280092155,0.0111313394643631,GNB1;SLC6A12;HAP1;SLC38A3;GABRD;ADCY5
190,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,6/89,0.9776167152979834,0.999995789583929,0,0,0.4917192280092155,0.0111313394643631,ZAP70;BATF3;PPP3R1;AKT2;CD247;PDCD1
191,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,7/100,0.9781198173318412,0.999995789583929,0,0,0.5118928693365031,0.0113246591043783,PLCB3;MAPK8;NOS3;AKT2;MMP2;PRKCD;PLCB2
192,KEGG_2021_Human,Progesterone-mediated oocyte maturation,7/100,0.9781198173318412,0.999995789583929,0,0,0.5118928693365031,0.0113246591043783,MAD2L2;MAPK8;AKT2;SPDYC;BRAF;CPEB4;ADCY5
193,KEGG_2021_Human,Acute myeloid leukemia,4/67,0.9783215775345008,0.999995789583929,0,0,0.4320393780064884,0.0094689429369981,SPI1;AKT2;ZBTB16;BRAF
194,KEGG_2021_Human,Glycolysis / Gluconeogenesis,4/67,0.9783215775345008,0.999995789583929,0,0,0.4320393780064884,0.0094689429369981,ALDH3B2;PGK1;DLAT;HK1
195,KEGG_2021_Human,Butanoate metabolism,1/28,0.9783882761572268,0.999995789583929,0,0,0.2522487289792726,0.0055113010912588,ACAT2
196,KEGG_2021_Human,Porphyrin and chlorophyll metabolism,2/43,0.979764218456818,0.999995789583929,0,0,0.3320928279705332,0.0067890831652924,CPOX;CP
197,KEGG_2021_Human,Toxoplasmosis,8/112,0.9805098470392288,0.999995789583929,0,0,0.5230165912518854,0.0102943214012311,HSPA8;LAMA5;MAPK8;AKT2;PPIF;LAMB1;BIRC7;PIK3R5
198,KEGG_2021_Human,Amoebiasis,7/102,0.981428915521512,0.999995789583929,0,0,0.5010584084672678,0.0093926867078452,LAMA5;PLCB3;ITGB2;LAMB1;CXCL2;PLCB2;VCL
199,KEGG_2021_Human,Longevity regulating pathway,7/102,0.981428915521512,0.999995789583929,0,0,0.5010584084672678,0.0093926867078452,RPTOR;HSPA8;STK11;CREB3L3;AKT2;EIF4EBP2;ADCY5
200,KEGG_2021_Human,Vasopressin-regulated water reabsorption,2/44,0.9820025184121274,0.999995789583929,0,0,0.3241672255756763,0.0058873326138862,CREB3L3;ARHGDIG
201,KEGG_2021_Human,Renal cell carcinoma,4/69,0.9821573674272074,0.999995789583929,0,0,0.4186976688151316,0.0075381204107453,FH;AKT2;RAPGEF1;BRAF
202,KEGG_2021_Human,Ascorbate and aldarate metabolism,1/30,0.9835693530736688,0.999995789583929,0,0,0.2348252936496163,0.0038903804724915,MIOX
203,KEGG_2021_Human,Endometrial cancer,3/58,0.9840122436706144,0.999995789583929,0,0,0.3711866215975805,0.0059823922316677,APC2;AKT2;BRAF
204,KEGG_2021_Human,Rheumatoid arthritis,6/93,0.9841622204096018,0.999995789583929,0,0,0.4690033509890822,0.0074874215271102,IL11;ITGB2;ATP6V0A4;LTB;CXCL2;ATP6V1C2
205,KEGG_2021_Human,T cell receptor signaling pathway,7/104,0.9842682050496228,0.999995789583929,0,0,0.4906707294895472,0.0077804936102417,ZAP70;PPP3R1;MAPK8;AKT2;CD247;PDCD1;MAP3K14
206,KEGG_2021_Human,IL-17 signaling pathway,6/94,0.9854922225464348,0.999995789583929,0,0,0.4636470504417213,0.0067757585376935,CSF3;CEBPB;MAPK8;CXCL2;CCL17;IL17B
207,KEGG_2021_Human,Non-small cell lung cancer,4/72,0.9867272040220222,0.999995789583929,0,0,0.4001566170712607,0.0053467593797523,RET;AKT2;RARB;BRAF
208,KEGG_2021_Human,Viral myocarditis,3/60,0.987089753079437,0.999995789583929,0,0,0.3581213307240704,0.0046535390323374,ITGB2;RAC3;ACTG1
209,KEGG_2021_Human,Lysosome,9/128,0.987322082216535,0.999995789583929,0,0,0.5139830745950793,0.0065578937795053,ABCA2;LAMP3;SLC11A1;GAA;ATP6V0A4;AP3S2;ABCB9;AP3B2;SGSH
210,KEGG_2021_Human,ErbB signaling pathway,5/85,0.9882484962032096,0.999995789583929,0,0,0.425039169604387,0.0050244298830213,SHC2;MAPK8;AKT2;CAMK2A;BRAF
211,KEGG_2021_Human,Oocyte meiosis,9/129,0.9882779117122396,0.999995789583929,0,0,0.5096704590035308,0.0060096944234391,MAD2L2;PPP3R1;SLK;SPDYC;CAMK2A;YWHAZ;CPEB4;ADCY5;PPP1CA
212,KEGG_2021_Human,Drug metabolism,7/108,0.9887737640876904,0.999995789583929,0,0,0.4711295512146275,0.0053189234087641,ALDH3B2;IMPDH1;MGST3;CYP1A2;GMPS;TK2;UCKL1
213,KEGG_2021_Human,Intestinal immune network for IgA production,2/48,0.9887813936245092,0.999995789583929,0,0,0.2959107300809689,0.0033384676925072,CCR9;MAP3K14
214,KEGG_2021_Human,"Valine, leucine and isoleucine degradation",2/48,0.9887813936245092,0.999995789583929,0,0,0.2959107300809689,0.0033384676925072,DBT;ACAT2
215,KEGG_2021_Human,Fructose and mannose metabolism,1/33,0.989108473925731,0.999995789583929,0,0,0.2127737583105201,0.0023301435067575,HK1
216,KEGG_2021_Human,PPAR signaling pathway,4/74,0.9891291346269766,0.999995789583929,0,0,0.3886788231345788,0.0042484091689226,FADS2;APOC3;ACSL3;ACOX3
217,KEGG_2021_Human,Colorectal cancer,5/86,0.9893042791854674,0.999995789583929,0,0,0.4197675936806371,0.0045138999594991,APC2;MAPK8;AKT2;RAC3;BRAF
218,KEGG_2021_Human,FoxO signaling pathway,9/131,0.9899913448332212,0.999995789583929,0,0,0.5012573236691985,0.0050421867596808,STK11;MAPK8;CCND2;AKT2;FOXO6;BRAF;SLC2A4;IL7R;S1PR4
219,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,9/131,0.9899913448332212,0.999995789583929,0,0,0.5012573236691985,0.0050421867596808,ZAP70;SHC2;PPP3R1;RAET1G;ITGB2;RAC3;BRAF;CD247;ULBP2
220,KEGG_2021_Human,Glioma,4/75,0.9901685031713944,0.999995789583929,0,0,0.3831824147705339,0.0037858978627349,SHC2;AKT2;CAMK2A;BRAF
221,KEGG_2021_Human,Apoptosis,10/142,0.9903180490018424,0.999995789583929,0,0,0.5146639075210504,0.0050072299158875,NTRK1;MAPK8;APAF1;AKT2;CAPN2;BIRC7;NGF;MAP3K14;ACTG1;TUBA8
222,KEGG_2021_Human,Pentose and glucuronate interconversions,1/34,0.9905034910083604,0.999995789583929,0,0,0.2063142176556333,0.0019686272316861,DCXR
223,KEGG_2021_Human,Pertussis,4/76,0.9911123990494354,0.999995789583929,0,0,0.3778386844166014,0.0033730910970445,C5;MAPK8;ITGB2;C1QC
224,KEGG_2021_Human,Gap junction,5/88,0.991151728342394,0.999995789583929,0,0,0.409605519610758,0.0036404305261208,PLCB3;TUBB1;PLCB2;ADCY5;TUBA8
225,KEGG_2021_Human,Systemic lupus erythematosus,9/135,0.9927387480537344,0.999995789583929,0,0,0.4852323039847559,0.0035362484012866,H4C8;C5;H4C2;H2AC16;MACROH2A1;ELANE;H3C7;H3-3A;C1QC
226,KEGG_2021_Human,DNA replication,1/36,0.9927804166607616,0.999995789583929,0,0,0.1945024861724118,0.0014093204052965,LIG1
227,KEGG_2021_Human,RNA degradation,4/79,0.9934509205192574,0.999995789583929,0,0,0.362662490211433,0.0023829169744452,CNOT4;PARN;TENT4B;EDC3
228,KEGG_2021_Human,Autophagy,9/137,0.9938295875141662,0.999995789583929,0,0,0.4775953805413888,0.0029560900549903,RPTOR;RUBCN;STK11;MAPK8;MTMR3;ATG16L2;AKT2;PRKCD;ULK2
229,KEGG_2021_Human,Retrograde endocannabinoid signaling,10/148,0.9939407811590693,0.999995789583929,0,0,0.4921165790731008,0.00299091252317,FAAH;PLCB3;MAPK8;DAGLA;CNR1;GNB1;SLC17A7;PLCB2;GABRD;ADCY5
230,KEGG_2021_Human,Pathways in cancer,50/531,0.9939998423062394,0.999995789583929,0,0,0.7029895187789925,0.0042307532943517,RET;SPI1;CCND2;AKT2;RAC3;APC2;APAF1;WNT5B;PLEKHG5;MMP2;WNT9B;FLT3LG;WNT9A;PGF;PLCB3;RARB;BIRC7;PLCB2;NOTCH2;NOTCH3;LAMA5;FH;ROCK2;MGST3;CAMK2A;PLD1;RASGRP2;RASGRP4;ADCY5;LRP6;PLD2;DLL3;MAPK8;DVL1;HES1;IL12RB1;WNT1;FGF22;NTRK1;ZBTB17;TXNRD3;WNT3A;ZBTB16;IGF2;BRAF;LAMB1;ESR1;GNB1;FGFR4;IL7R
231,KEGG_2021_Human,NF-kappa B signaling pathway,6/104,0.99411281862334,0.999995789583929,0,0,0.4160962190518841,0.002456873057365,CARD10;ZAP70;LTB;CARD14;MAP3K14;CXCL2
232,KEGG_2021_Human,Staphylococcus aureus infection,5/95,0.995503312087596,0.999995789583929,0,0,0.3775949862906385,0.0017017558169962,C5;KRT19;KRT16;ITGB2;C1QC
233,KEGG_2021_Human,"Glycine, serine and threonine metabolism",1/40,0.9958273569245084,0.999995789583929,0,0,0.1745134021238831,0.00072970560041676,AGXT
234,KEGG_2021_Human,AMPK signaling pathway,7/120,0.9960826276962472,0.999995789583929,0,0,0.4208066938871794,0.001651693753912,RPTOR;SREBF1;STK11;CREB3L3;PPP2R2B;AKT2;SLC2A4
235,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,9/143,0.996246991694377,0.999995789583929,0,0,0.456052417395174,0.0017147883342428,APC2;WNT5B;WNT3A;AKT2;DVL1;WNT9B;WNT9A;WNT1;FGFR4
236,KEGG_2021_Human,HIF-1 signaling pathway,6/109,0.9963067886529784,0.999995789583929,0,0,0.3957832425358371,0.0014644170307034,NOS3;AKT2;CAMK2A;MKNK2;PGK1;HK1
237,KEGG_2021_Human,Homologous recombination,1/41,0.99636177140517,0.999995789583929,0,0,0.1701407899882675,0.0006201398778986586,NBN
238,KEGG_2021_Human,Melanoma,3/72,0.9965398854950176,0.999995789583929,0,0,0.2956351569811963,0.0010247053178406,AKT2;BRAF;FGF22
239,KEGG_2021_Human,mRNA surveillance pathway,5/98,0.996655015331973,0.999995789583929,0,0,0.3653513260806388,0.0012241430974458,DAZAP1;CPSF1;PPP2R2B;SMG6;PPP1CA
240,KEGG_2021_Human,TNF signaling pathway,6/112,0.9972202917244154,0.999995789583929,0,0,0.3845152895250488,0.0010703286231895,CEBPB;MAPK8;CREB3L3;AKT2;MAP3K14;CXCL2
241,KEGG_2021_Human,Transcriptional misregulation in cancer,13/192,0.9976204812410776,0.999995789583929,0,0,0.4926276739361877,0.0011736136635801,NTRK1;ZBTB17;MEF2C;CEBPB;SPI1;ZBTB16;BAIAP3;CCND2;FEV;NSD2;ELANE;H3C7;H3-3A
242,KEGG_2021_Human,Steroid hormone biosynthesis,2/61,0.9976652804313032,0.999995789583929,0,0,0.2305376515211798,0.000538870066636781,CYP21A2;CYP1A2
243,KEGG_2021_Human,Chronic myeloid leukemia,3/76,0.9977932196929218,0.999995789583929,0,0,0.2793716323083934,0.0006171930720410508,SHC2;AKT2;BRAF
244,KEGG_2021_Human,Metabolism of xenobiotics by cytochrome P450,3/76,0.9977932196929218,0.999995789583929,0,0,0.2793716323083934,0.0006171930720410508,ALDH3B2;MGST3;CYP1A2
245,KEGG_2021_Human,Leishmaniasis,3/77,0.998029314953513,0.999995789583929,0,0,0.2755804728407468,0.0005436181431103946,ITGB2;NCF4;EEF1A2
246,KEGG_2021_Human,Morphine addiction,4/91,0.9981326177530816,0.999995789583929,0,0,0.3124240542219101,0.0005839605409913743,GNB1;ADORA1;GABRD;ADCY5
247,KEGG_2021_Human,Proteasome,1/46,0.9981661969416616,0.999995789583929,0,0,0.1511928040672663,0.0002775123558411193,PSMC6
248,KEGG_2021_Human,Cytosolic DNA-sensing pathway,2/63,0.9981727221719578,0.999995789583929,0,0,0.2229533851561097,0.0004077704458940721,ZBP1;POLR1C
249,KEGG_2021_Human,Phagosome,9/152,0.9982601322015114,0.999995789583929,0,0,0.4271275997443122,0.0007437927950010375,COMP;CLEC4M;NCF4;TUBB1;ITGB2;ATP6V0A4;ACTG1;ATP6V1C2;TUBA8
250,KEGG_2021_Human,Pathogenic Escherichia coli infection,13/197,0.9983848858376804,0.999995789583929,0,0,0.4791022465191765,0.0007744303887805443,ROCK2;ACTG1;MAPK8;CLDN9;MYO1A;NCL;TUBB1;MYH11;ARHGEF2;CLDN16;TLR5;MYO1F;TUBA8
251,KEGG_2021_Human,Inflammatory bowel disease,2/65,0.9985709340445,0.999995789583929,0,0,0.2158506595126313,0.00030868544748516817,TLR5;IL12RB1
252,KEGG_2021_Human,Endocytosis,18/252,0.9986400563279988,0.999995789583929,0,0,0.5211387038158691,0.0007092016290000694,WASHC5;HSPA8;ZFYVE9;IQSEC3;PLD1;AP2A2;RNF41;PLD2;SPART;GRK1;PSD2;PIP5KL1;RUFY2;STAMBP;LDLRAP1;FGFR4;SMAP2;SPG21
253,KEGG_2021_Human,Th17 cell differentiation,5/107,0.9986478725222095,0.999995789583929,0,0,0.3329416372894633,0.0004504841609653326,ZAP70;PPP3R1;MAPK8;CD247;IL12RB1
254,KEGG_2021_Human,Ribosome biogenesis in eukaryotes,5/108,0.9987791755592124,0.999995789583929,0,0,0.3296901798379215,0.0004027397167298157,RNA5S12;UTP4;RPP30;EFL1;DROSHA
255,KEGG_2021_Human,Hepatitis C,9/157,0.998876949899658,0.999995789583929,0,0,0.4125783296046144,0.0004636065098841367,APAF1;CLDN9;PPP2R2B;AKT2;MX2;BRAF;CLDN16;YWHAZ;PIAS1
256,KEGG_2021_Human,Tuberculosis,11/180,0.9989122707580956,0.999995789583929,0,0,0.4414126841416866,0.00048039880359297454,PPP3R1;CEBPB;MAPK8;CLEC4M;APAF1;AKT2;SPHK1;ITGB2;CAMK2A;CARD9;ATP6V0A4
257,KEGG_2021_Human,Diabetic cardiomyopathy,13/203,0.9989944923189128,0.999995789583929,0,0,0.463811394891945,0.000466600544688164,ACE;NOS3;MMP2;PRKCD;NCF4;CAMK2A;SLC2A4;PPP1CA;PLCB3;MAPK8;AKT2;PPIF;PLCB2
258,KEGG_2021_Human,Retinol metabolism,2/68,0.999012825597795,0.999995789583929,0,0,0.2060036989614454,0.0002034620211550281,CYP26A1;CYP1A2
259,KEGG_2021_Human,Prostate cancer,4/97,0.9990194115299316,0.999995789583929,0,0,0.2921666203551671,0.00028663577810791006,CREB3L3;AKT2;INSRR;BRAF
260,KEGG_2021_Human,Protein processing in endoplasmic reticulum,10/171,0.9991022213031756,0.999995789583929,0,0,0.4212535468081164,0.0003783623285301198,HSPA8;MAPK8;LMAN1L;WFS1;DNAJC5B;CAPN2;SSR1;UBE4B;YOD1;MARCHF6
261,KEGG_2021_Human,Cell cycle,6/124,0.9991331676192752,0.999995789583929,0,0,0.3451729451144997,0.0002993368419606033,MAD2L2;ZBTB17;CCND2;ORC2;SFN;YWHAZ
262,KEGG_2021_Human,Yersinia infection,7/137,0.9991914513899612,0.999995789583929,0,0,0.3654192925851099,0.00029557877211313234,ZAP70;MAPK8;ROCK2;AKT2;LIMK1;RAC3;ACTG1
263,KEGG_2021_Human,Autoimmune thyroid disease,1/53,0.9992964361317184,0.999995789583929,0,0,0.1307872807677266,9.204959036030952e-05,TPO
264,KEGG_2021_Human,Measles,7/139,0.9993320316998844,0.999995789583929,0,0,0.3598410605466662,0.00024044273453052928,HSPA8;MAPK8;CCND2;CLEC4M;APAF1;AKT2;MX2
265,KEGG_2021_Human,Toll-like receptor signaling pathway,4/104,0.9995423438526146,0.999995789583929,0,0,0.2716053249804229,0.0001243302990732958,MAPK8;AKT2;IRF5;TLR5
266,KEGG_2021_Human,Viral carcinogenesis,12/203,0.99959472578289,0.999995789583929,0,0,0.4257001024088705,0.00017256024519885315,H4C8;DDB1;HDAC5;VAC14;KAT2A;CCND2;HDAC10;CREB3L3;H4C2;HDAC8;YWHAZ;GTF2E2
267,KEGG_2021_Human,Necroptosis,8/159,0.9996819341083746,0.999995789583929,0,0,0.3592468510583041,0.00011428234561717107,ZBP1;MAPK8;PLA2G4D;PLA2G4C;CAMK2A;CAPN2;H2AC16;MACROH2A1
268,KEGG_2021_Human,Hepatitis B,8/162,0.9997602234827891,0.999995789583929,0,0,0.3521874204227145,8.445639880966036e-05,DDB1;MAPK8;CREB3L3;APAF1;AKT2;BRAF;HSPG2;YWHAZ
269,KEGG_2021_Human,Thermogenesis,14/232,0.9997641307647503,0.999995789583929,0,0,0.4347989152385898,0.00010256778439266944,COX19;COA1;ACTL6B;KDM1A;BMP8B;ACSL3;SMARCA4;ADCY5;ACTG1;RPTOR;CREB3L3;CNR1;DPF1;ATP5MG
270,KEGG_2021_Human,MicroRNAs in cancer,21/310,0.9997995690359956,0.999995789583929,0,0,0.4912935611769343,9.848031165749506e-05,APC2;NOTCH2;NOTCH3;HDAC5;MIR28;TNXB;WNT3A;MIR30C2;MIR1-1;RPTOR;EFNA3;CCND2;EFNA2;MIR221;MIR133A2;MIR125B1;MIR150;SOX4;MIR129-1;MIR129-2;MIR181B2
271,KEGG_2021_Human,Salmonella infection,15/249,0.999852669185434,0.999995789583929,0,0,0.4337699264950543,6.391238485221575e-05,GSDMD;ANXA2;ROCK2;AHNAK2;SNX33;MYL12B;ACTG1;MAPK8;AKT2;TUBB1;MYL10;TLR5;MYL9;VPS16;TUBA8
272,KEGG_2021_Human,Lipid and atherosclerosis,12/215,0.999853381777688,0.999995789583929,0,0,0.4002569470511069,5.868926460757987e-05,HSPA8;PPP3R1;PLCB3;MAPK8;APAF1;ROCK2;NOS3;AKT2;NCF4;CAMK2A;PLCB2;CXCL2
273,KEGG_2021_Human,NOD-like receptor signaling pathway,9/181,0.9998723713311184,0.999995789583929,0,0,0.3545165910936345,4.524936823743076e-05,GSDMD;GBP5;PLCB3;MAPK8;PRKCD;CARD9;NLRP1;CXCL2;PLCB2
274,KEGG_2021_Human,Prion disease,17/273,0.9998726088372352,0.999995789583929,0,0,0.4491372737111374,5.721976426257819e-05,RYR1;HSPA8;APAF1;PRKCD;NCF4;GRIN2C;GRIN1;C5;PPP3R1;GRIN3B;MAPK8;PSMC6;CREB3L3;TUBB1;PPIF;C1QC;TUBA8
275,KEGG_2021_Human,Alzheimer disease,26/369,0.9998741975258332,0.999995789583929,0,0,0.511901307577872,6.440250210446896e-05,CHRM1;LRP1;LRP6;PPP3R1;MAPK8;AKT2;TUBB1;DVL1;CAPN2;WNT1;APC2;WNT5B;APAF1;WNT3A;WNT9B;BRAF;WNT9A;GRIN2C;GRIN1;PLCB3;PSMC6;PPIF;ULK2;PLCB2;CDK5R1;TUBA8
276,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,12/219,0.9998956369774188,0.999995789583929,0,0,0.3924314354998463,4.095746802444763e-05,VAC14;PPP3R1;KAT2A;MAPK8;SPI1;CCND2;CREB3L3;AKT2;ITGB2;TLN2;MAP3K14;ADCY5
277,KEGG_2021_Human,Mitophagy,1/68,0.9999075922109504,0.999995789583929,0,0,0.1014189903046363,9.372337706868816e-06,MAPK8
278,KEGG_2021_Human,Oxidative phosphorylation,5/133,0.999910067697099,0.999995789583929,0,0,0.2649150509204857,2.382549195915269e-05,ATP4B;ATP4A;ATP6V0A4;ATP5MG;ATP6V1C2
279,KEGG_2021_Human,RIG-I-like receptor signaling pathway,1/70,0.9999290268399064,0.999995789583929,0,0,0.0984679736783935,6.988831272637532e-06,MAPK8
280,KEGG_2021_Human,Epstein-Barr virus infection,10/202,0.9999420305894186,0.999995789583929,0,0,0.3526049843014128,2.044089558709276e-05,FCER2;MAPK8;PSMC6;CCND2;APAF1;AKT2;ENTPD8;HES1;CD247;MAP3K14
281,KEGG_2021_Human,Huntington disease,19/306,0.999944269250496,0.999995789583929,0,0,0.4473008523479709,2.4929106420446506e-05,DNAH11;DNAI2;DNAH2;KCNJ10;APAF1;AP2A2;GRIN1;PLCB3;MAPK8;PSMC6;CREB3L3;POLR2B;TUBB1;PPIF;ULK2;HAP1;PLCB2;DNAI1;TUBA8
282,KEGG_2021_Human,Chemical carcinogenesis,13/239,0.9999477063140648,0.999995789583929,0,0,0.3891162612792739,2.034885562253591e-05,NOTCH2;CHRNA3;CHRNA4;MGST3;AIP;ESR1;ADCY5;DLL3;CREB3L3;AKT2;CYP1A2;WNT1;FGF22
283,KEGG_2021_Human,Ubiquitin mediated proteolysis,5/140,0.9999561190199404,0.999995789583929,0,0,0.2510771641206424,1.1017753768851912e-05,DDB1;SIAH1;UBE4B;BIRC7;PIAS1
284,KEGG_2021_Human,Cellular senescence,6/156,0.9999642996198408,0.999995789583929,0,0,0.2710344827586207,9.676206793865569e-06,PPP3R1;CCND2;AKT2;CAPN2;NBN;PPP1CA
285,KEGG_2021_Human,Pathways of neurodegeneration,34/475,0.9999707723994952,0.999995789583929,0,0,0.5193085157993467,1.5178363653138565e-05,RYR1;CHRM1;DNAH2;CAMK2A;SLC6A3;LRP6;PPP3R1;MAPK8;TUBB1;DVL1;CAPN2;WNT1;DNAI1;APC2;DNAH11;DNAI2;APAF1;WNT5B;WNT3A;WNT9B;SEPTIN5;BRAF;WNT9A;GRIN2C;GRIN1;FIG4;PLCB3;PSMC6;PPIF;ULK2;HAP1;PLCB2;TUBA8;CDK5R1
286,KEGG_2021_Human,Antigen processing and presentation,1/78,0.9999741805930308,0.999995789583929,0,0,0.0881969028234182,2.27722112578868e-06,HSPA8
287,KEGG_2021_Human,Spliceosome,5/150,0.9999828421789572,0.999995789583929,0,0,0.2336264300282291,4.008554866432558e-06,HSPA8;RBM17;SRSF10;SRSF8;BCAS2
288,KEGG_2021_Human,Human immunodeficiency virus 1 infection,9/212,0.9999896140169784,0.999995789583929,0,0,0.2998394038423259,3.1141431292629483e-06,DDB1;PPP3R1;MAPK8;APOBEC3H;AKT2;GNB1;LIMK1;RAC3;CD247
289,KEGG_2021_Human,RNA transport,7/186,0.9999901556919382,0.999995789583929,0,0,0.2646371562033949,2.605182513404789e-06,NUP214;NUP205;EIF2B3;NUP188;RPP30;EEF1A2;EIF4EBP2
290,KEGG_2021_Human,Human cytomegalovirus infection,9/225,0.9999938507614928,0.999995789583929,0,0,0.281581012161632,1.7315141265928829e-06,PPP3R1;PLCB3;CREB3L3;ROCK2;AKT2;GNB1;RAC3;PLCB2;ADCY5
291,KEGG_2021_Human,Herpes simplex virus 1 infection,19/498,0.999994203403317,0.999995789583929,0,0,0.2650074289928883,1.536145636078722e-06,EIF2B3;APAF1;ZNF282;CARD9;PPP1CA;C5;ZNF707;ZNF93;ZNF83;AKT2;ZNF836;TNFRSF14;ZNF611;ZNF853;ZNF721;ZNF510;SRSF8;ZNF431;ZNF354B
292,KEGG_2021_Human,Olfactory transduction,8/440,0.9999943991541406,0.999995789583929,0,0,0.1235294117647058,6.91871131934082e-07,GUCY2D;OR51D1;GNB1;CAMK2A;OR56B1;NCALD;SLC8A2;OR7G3
293,KEGG_2021_Human,Amyotrophic lateral sclerosis,18/364,0.9999945674157916,0.999995789583929,0,0,0.3501524737153521,1.9022379662683835e-06,NUP214;NUP205;DNAH11;DNAI2;DNAH2;NUP188;APAF1;GRIN2C;GRIN1;ACTG1;FIG4;PPP3R1;PSMC6;TUBB1;ULK2;HAP1;DNAI1;TUBA8
294,KEGG_2021_Human,Influenza A,5/172,0.9999947114486886,0.999995789583929,0,0,0.2025912921513025,1.0714172769168236e-06,APAF1;AKT2;MX2;ACTG1;TMPRSS11D
295,KEGG_2021_Human,Parkinson disease,10/249,0.9999947458286124,0.999995789583929,0,0,0.282492462707645,1.4842677140833422e-06,MAPK8;PSMC6;APAF1;TUBB1;CAMK2A;SEPTIN5;PPIF;SLC6A3;ADCY5;TUBA8
296,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,6/193,0.9999950851286638,0.999995789583929,0,0,0.2169421487603305,1.0662453687977245e-06,PPP3R1;MAPK8;AKT2;GNB1;CXCL2;PIK3R5
297,KEGG_2021_Human,Coronavirus disease,8/232,0.9999951883483352,0.999995789583929,0,0,0.2411484593837535,1.1603251776201347e-06,FGB;C5;CSF3;MAPK8;ACE;MX2;RPL36;C1QC
298,KEGG_2021_Human,Non-alcoholic fatty liver disease,3/155,0.9999957652915418,0.999995789583929,0,0,0.1335616438356164,5.655958204131183e-07,SREBF1;MAPK8;AKT2
299,KEGG_2021_Human,Ribosome,3/158,0.999995789583929,0.999995789583929,0,0,0.1309538539233634,5.513713718725982e-07,RNA5S12;RPL36;MRPL33
